Subtopic Deep Dive

← Biological Research and Disease Studies

Synthetic Phosphoethanolamine Anticancer Effects
Research Guide

What is Synthetic Phosphoethanolamine Anticancer Effects?

Synthetic phosphoethanolamine (Pho-s) is a synthetic phospholipid analog that induces apoptosis and inhibits proliferation in various cancer cells through targeted biochemical pathways.

Research demonstrates Pho-s's anti-angiogenic and anti-metastatic effects in lung cancer models (Ferreira et al., 2013, 58 citations). It shows efficacy against Ehrlich ascites tumors (Ferreira et al., 2012, 57 citations) and leukemia cells both in vitro and in vivo (Ferreira et al., 2013, 46 citations). Later studies explore liposomal formulations for hepatocellular carcinoma (Luna et al., 2018, 11 citations) and theoretical molecular mechanisms (Lorenzo et al., 2016, 5 citations). Approximately 10 key papers exist on this topic.

Curated Papers

Key Challenges

Why It Matters

Pho-s offers a low-cost alternative to conventional chemotherapeutics, inhibiting metastasis in lung cancer models (Ferreira et al., 2013). It targets Ehrlich ascites tumors and leukemia, suggesting broad-spectrum potential (Ferreira et al., 2012; Ferreira et al., 2013). Liposomal DODAC/Pho-s enhances apoptosis in hepatocellular carcinoma via intrinsic and extrinsic pathways (Luna et al., 2018). Clinical opinions highlight social media-driven interest despite regulatory hurdles (Rêgo et al., 2017). Theoretical studies support its antitumor activity across cell types (Lorenzo et al., 2016).

Key Research Challenges

Mechanistic Pathway Elucidation

Unclear signaling cascades limit translation of Pho-s effects from preclinical models to clinics. Ferreira et al. (2013) show anti-angiogenic activity but lack detailed pathway mapping. Theoretical modeling reveals broad activity without specific receptor interactions (Lorenzo et al., 2016).

Clinical Translation Barriers

Regulatory and safety concerns hinder trials despite promising preclinical data. Oncologists report patient use via social media without evidence (Rêgo et al., 2017). Recent critiques question biological effects without standardized protocols (Rossini, 2023).

Efficacy Across Cancer Types

Variable responses across tumors challenge broad application. Pho-s works in leukemia and ascites tumors (Ferreira et al., 2013; Ferreira et al., 2012) but needs validation in solid tumors like glioblastoma (Medina, 2023).

Essential Papers

Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine

Adilson Kleber Ferreira, Vanessa M. Freitas, Débora Levy et al. · 2013 · PLoS ONE · 58 citations

Taken together, our findings provide evidence that Pho-s is a compound that potently inhibits lung metastasis, suggesting that it is a promising novel candidate drug for future developments.

Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study.

Adilson Kleber Ferreira, Renato Meneguelo, Alexandre Pereira et al. · 2012 · PubMed · 57 citations

These findings suggest that Pho-s is a potential anticancer candidate drug.

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects

Adilson Kleber Ferreira, Bárbara A. Santana-Lemos, Eduardo Magalhães Rego et al. · 2013 · British Journal of Cancer · 46 citations

Antiproliferative and proapoptotic effects of DODAC/synthetic phosphoethanolamine on hepatocellular carcinoma cells

Arthur Cássio de Lima Luna, Greice Kelle Viegas Saraiva, Gilberto Orivaldo Chierice et al. · 2018 · BMC Pharmacology and Toxicology · 11 citations

The overall results showed that DODAC/PHO-S liposomes were more effective than PHO-S alone, in promoting cytotoxicity Hepa1c1c7 tumor cells, activating the intrinsic and extrinsic pathways of progr...

Theoretical Study of Phosphoethanolamine: A Synthetic Anticancer Agent with Broad Antitumor Activity

Vitor Prates Lorenzo, Francisco Jaime Bezerra Mendonça, José Maria Barbosa‐Filho et al. · 2016 · Journal of Chemistry · 5 citations

Cancer is a major public health problem with limited success of available treatments, pointing to the need for new strategies to be developed. Phosphoethanolamine exhibits broad antitumor activity ...

Synthetic phosphoethanolamine: the state of the art of scientific production

Lucas de Barros Anastácio, Camila Rocha Delmaschio, Danielle A. G. Cavalcanti Oliveira et al. · 2018 · Brazilian Journal of Pharmaceutical Sciences · 4 citations

ABSTRACT Cancer is a multifactorial disease and a serious public health problem. Currently, alternative drug treatments for cancer are actively being sought, which is the case of synthetic phosphoe...

A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamine

Juliana Florinda M. Rêgo, Gilberto Lopes, Rachel P. Riechelmann et al. · 2017 · Revista da Associação Médica Brasileira · 4 citations

Summary Introduction: Patients who are treating cancer have often used alternative therapies. In the internet era, information can be broadcasted widely, and this happened with phosphoethanolamine ...

Reading Guide

Foundational Papers

Start with Ferreira et al. (2013, 58 citations) for anti-metastatic effects, Ferreira et al. (2012, 57 citations) for ascites tumor data, and Ferreira et al. (2013, 46 citations) for leukemia to grasp core preclinical evidence.

Recent Advances

Study Luna et al. (2018) for liposomal advances, Anastácio et al. (2018) for production review, and Rossini (2023) for critical biological analysis.

Core Methods

Core techniques: in vitro/in vivo proliferation assays (Ferreira et al., 2012), liposome formulation (Luna et al., 2018), DFT modeling (Lorenzo et al., 2016), and pharmacological interaction studies (Medina, 2023).

How PapersFlow Helps You Research Synthetic Phosphoethanolamine Anticancer Effects

Discover & Search

Research Agent uses searchPapers and exaSearch to find core Pho-s papers like 'Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine' (Ferreira et al., 2013), then citationGraph reveals 58 citing works and findSimilarPapers uncovers liposomal variants (Luna et al., 2018).

Analyze & Verify

Analysis Agent applies readPaperContent to extract apoptosis mechanisms from Ferreira et al. (2012), verifies claims with CoVe against 57 citing papers, and runs PythonAnalysis on dose-response data for statistical significance (p-values, IC50 curves) with GRADE scoring for evidence strength in preclinical efficacy.

Synthesize & Write

Synthesis Agent detects gaps in clinical data via contradiction flagging between preclinical promise (Ferreira et al., 2013) and oncologist surveys (Rêgo et al., 2017); Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to draft reviews with embedded mechanisms diagrams via exportMermaid.

Use Cases

"Plot dose-response curves of Pho-s on Ehrlich ascites tumors from key papers."

Research Agent → searchPapers → Analysis Agent → readPaperContent (Ferreira et al., 2012) → runPythonAnalysis (pandas/matplotlib IC50 fitting) → matplotlib survival plot output.

"Write LaTeX review on Pho-s anti-leukemia effects with citations."

Synthesis Agent → gap detection → Writing Agent → latexEditText (abstract synthesis) → latexSyncCitations (Ferreira et al., 2013) → latexCompile → PDF review output.

"Find code for Pho-s molecular simulations in cancer studies."

Research Agent → paperExtractUrls (Lorenzo et al., 2016) → paperFindGithubRepo → githubRepoInspect → Python simulation scripts for phosphoethanolamine docking.

Automated Workflows

Deep Research workflow conducts systematic review of 10+ Pho-s papers: searchPapers → citationGraph → GRADE grading → structured report on efficacy. DeepScan applies 7-step analysis with CoVe checkpoints to verify anti-metastatic claims (Ferreira et al., 2013). Theorizer generates hypotheses on Pho-s pathways from abstracts like Luna et al. (2018).

Try Doxa for Synthetic Phosphoethanolamine Anticancer Effects Research

Frequently Asked Questions

What is synthetic phosphoethanolamine?

Synthetic phosphoethanolamine (Pho-s) is a phospholipid analog inducing cancer cell apoptosis and inhibiting proliferation (Ferreira et al., 2012).

What are key methods studied?

Methods include in vivo metastasis assays (Ferreira et al., 2013), liposomal delivery for apoptosis (Luna et al., 2018), and theoretical molecular modeling (Lorenzo et al., 2016).

What are the most cited papers?

Top papers are Ferreira et al. (2013, 58 citations) on anti-angiogenic effects, Ferreira et al. (2012, 57 citations) on ascites tumors, and Ferreira et al. (2013, 46 citations) on leukemia.